[Federal Register Volume 67, Number 181 (Wednesday, September 18, 2002)]
[Notices]
[Page 58813]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-23637]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in section 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, HIV Vaccine Design and Development 
Teams.
    Date: October 9-10, 2002.
    Time: 8:30 AM to 4 PM.
    Agenda: To review and evaluate contract proposals.
    Place: 2101 Wisconsin Ave., NW., Washington, DC 20007.
    Contact Person: Geetha P. Bansal, PhD., Scientific Review 
Administrator, NIAID/DEA, Scientific Review Program, Room 2217, 
6700B Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616, 301-496-
2550, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: September 11, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-23637 Filed 9-17-02; 8:45 am]
BILLING CODE 4140-01-M